You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) Antibodies

MYH9 encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). Additionally we are shipping Non-Muscle Myosin Heavy Polypeptide 9 Kits (16) and Non-Muscle Myosin Heavy Polypeptide 9 Proteins (6) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
MYH9 4627 P35579
MYH9 25745 Q62812
MYH9 17886 Q8VDD5
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Non-Muscle Myosin Heavy Polypeptide 9 Antibodies at antibodies-online.com

Showing 10 out of 102 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Chicken Rabbit Un-conjugated WB WB Suggested Anti-MYH9 Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:2500Positive Control: MCF7 cell lysate 100 μL Log in to see 2 to 3 Days
$289.00
Details
Human Mouse Un-conjugated EIA, IF, IHC (p), WB 50 μg Log in to see 6 to 8 Days
$566.50
Details
Human Rabbit Un-conjugated IHC (p), WB Human Tonsil: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μg Log in to see 8 to 10 Days
$676.50
Details
Human Mouse Un-conjugated IF, IHC (p), ELISA, WB Immunoperoxidase of monoclonal antibody to MYH9 on formalin-fixed paraffin-embedded human ovarian cancer. [antibody concentration 0.7 ug/ml] Detection limit for recombinant GST tagged MYH9 is approximately 0.03ng/ml as a capture antibody. 100 μg Log in to see 9 Days
$430.00
Details
Human Mouse Un-conjugated EIA, IF, IHC (p), WB 50 μg Log in to see 6 to 8 Days
$566.50
Details
Human Rabbit Un-conjugated WB MYH9 Antibody (C-term)  western blot analysis in Jurkat cell line lysates (35ug/lane).This demonstrates the MYH9 antibody detected the MYH9 protein (arrow). 400 μL Log in to see 10 to 11 Days
$324.50
Details
Human Mouse Un-conjugated ELISA, WB Detection limit for recombinant GST tagged MYH9 is approximately 0.03 ng/mL as a capture antibody. 0.1 mg Log in to see 8 to 11 Days
$450.00
Details
Dog Rabbit Un-conjugated WB Western blot analysis of Myosin 9 expression in A549 (A), rat testis (B), PC12 (C) whole cell lysates. 200 μL Log in to see 9 Days
$487.50
Details
Human Rabbit Un-conjugated IP, IHC (p), WB WB Image MYH9 antibody [N1], N-term detects MYH9 protein by Western blot analysis. A. 30 µg NT2D1 whole cell lysate/extract B. 30 µg PC-3 whole cell lysate/extract 5 % SDS-PAGE MYH9 antibody [N1], N-term , dilution: 1:1000 IHC-P Image Immunohistochemical analysis of paraffin-embedded human adenocarcinoma, using MYH9, antibody at 1:500 dilution. 100 μL Log in to see 2 to 3 Days
$358.60
Details
Human Rabbit Un-conjugated ELISA, WB 50 μg Log in to see 2 to 3 Days
$433.13
Details

MYH9 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
,
,
, , , , ,
Rat (Rattus)


Mouse (Murine)


Top referenced anti-Non-Muscle Myosin Heavy Polypeptide 9 Antibodies

  1. Human Monoclonal MYH9 Primary Antibody for IF, IHC (p) - ABIN518147 : Betapudi, Gokulrangan, Chance, Egelhoff: A proteomic study of myosin II motor proteins during tumor cell migration. in Journal of molecular biology 2011 (PubMed)
    Show all 2 references for ABIN518147

More Antibodies against Non-Muscle Myosin Heavy Polypeptide 9 Interaction Partners

Human Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) interaction partners

  1. the present study indicated that knockdown of NMIIA inhibited the migration and invasion of gastric cancer cells, which may be, at least in part, mediated via the JNK (show MAPK8 Antibodies) signaling pathway.

  2. Knocking down myosin-9 or promoting protein S-glutathionylation by knocking down glutaredoxin-1 (show GRX1 Antibodies) inhibited the death of airway smooth muscle cells by heating to simulate bronchial thermoplasty

  3. Severity and progression of sensorineural hearing loss appeared to depend on the specific NMMHC-IIA mutation in patients with MYH9-related disease.

  4. 7 members in 3 generations of a family had macrothrombocytopenia without Alport syndrome, and they all had a p.A95V mutation in exon 1 of MYH9. This affects the motor domain.

  5. heterozygotic form (allele A) of the MYH9 gene could be considered a very early marker, a new risk factor for the appearance of CKD, or a sign of renal frailty in elderly people.

  6. concordant with the genetic interaction observed in sickle cell disease patients, APOL1 (show APOL1 Antibodies) G2 reduces myh9 expression in vivo, suggesting a possible interaction between the altered APOL1 (show APOL1 Antibodies) and myh9.

  7. myosin IIA and IIB heavy chains play distinct and non-redundant roles in matrix remodeling

  8. Inhibition of NMMHC IIA impedes TF expression and venous thrombosis via Akt (show AKT1 Antibodies)/GSK3beta (show GSK3b Antibodies)-NF-kappaB (show NFKB1 Antibodies) signalling pathways in the endothelium both in vitro and in vivo.

  9. revealed that MYH9 is expressed in a subset of NSCLC with a more malignant nature, and its expression is an indicator of a poorer survival probability

  10. R705H mutation of MYH9 is associated with MYH9-related disease characterized by hearing impairment, thrombocytopenia, giant platelets, leukocyte inclusions, and mild to moderate elevation of some liver enzymes

Xenopus laevis Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) interaction partners

  1. Data show that the locomotion and blebbing of the primordial germ cells (PGCs) required F-actin, myosin II activity and RhoA/Rho-associated protein kinase (ROCK) signaling.

Mouse (Murine) Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) interaction partners

  1. Conditional deletion of nonmuscle myosin II-A in mouse tongue epithelium results in squamous cell carcinoma

  2. Inhibition of NMMHC IIA impedes TF expression and venous thrombosis via Akt (show AKT1 Antibodies)/GSK3beta (show GSK3b Antibodies)-NF-kappaB (show NFKB1 Antibodies) signalling pathways in the endothelium both in vitro and in vivo.

  3. Myh9 mediates colitis-induced epithelium injury by restricting Lgr5 (show LGR5 Antibodies)+ stem cells

  4. Mst1 (show MST1 Antibodies) regulates Myosin IIa dynamics to organize high and low affinity LFA-1 (show ITGAL Antibodies) to the anterior and posterior membrane during T cell migration.

  5. DDR1 malfunction causes outer hair cells deformation and the separation of the lateral wall, the location of the cellular motor responsible for the electromotile property, explicitly in those regions showing DDR1 and NM-IIA co-localization.

  6. A new role for Arl13b (show ARL13B Antibodies) in actin cytoskeleton remodeling through the interaction with Myh9.

  7. Lgl1 (show Klra7 Antibodies) forms two distinct complexes in vivo, Lgl1 (show Klra7 Antibodies)-NMIIA and Lgl1 (show Klra7 Antibodies)-Par6alpha (show PARD6A Antibodies)-aPKCzeta (show PRKCZ Antibodies), and that the formation of these complexes is affected by the phosphorylation state of Lgl1 (show Klra7 Antibodies).

  8. While MyoIIA activity is required for F-actin localization at the plasma membrane, it alone is insufficient to localize F-actin to the plasma membrane.

  9. The Myh9 R702C missense mutation results in the MYH9 disorder phenotype.

  10. Podocyte-specific deletion of Myh9 results in a variable susceptibility to glomerulosclerosis in response to different models of glomerular injury.

Zebrafish Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) interaction partners

  1. Results demonstrate an important role of NMHC-IIA for the proper formation and function of the glomerulus in zebrafish.

Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) Antigen Profile

Protein Summary

This gene encodes a conventional non-muscle myosin\; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.

Gene names and symbols associated with MYH9

  • myosin, heavy chain 9, non-muscle (MYH9) antibody
  • myosin, heavy chain 9, non-muscle (Myh9) antibody
  • myosin, heavy chain 9, non-muscle (myh9) antibody
  • myosin, heavy polypeptide 9, non-muscle (Myh9) antibody
  • myosin, heavy polypeptide 9a, non-muscle (myh9a) antibody
  • BDPLT6 antibody
  • C80049 antibody
  • D0Jmb2 antibody
  • dfna17 antibody
  • E030044M24Rik antibody
  • epsts antibody
  • fi22c04 antibody
  • Fltn antibody
  • ftns antibody
  • KLG/PTK7 antibody
  • MHA antibody
  • myh9 antibody
  • myh9l2 antibody
  • Myhn-1 antibody
  • Myhn1 antibody
  • myosin antibody
  • nmhc-ii-a antibody
  • NMHC II-A antibody
  • NMHCIIA antibody
  • NMMHC antibody
  • NMMHC-A antibody
  • NMMHC-IIA antibody
  • nmmhca antibody
  • NMMHC II-a antibody
  • non-muscle antibody
  • nonmuscle antibody
  • TU72.6 antibody
  • wu:fi22c04 antibody
  • wu:fj85e11 antibody
  • zgc:66164 antibody
  • zgc:162029 antibody

Protein level used designations for MYH9

cellular myosin heavy chain, type A , myosin heavy chain 9 , myosin heavy chain, non-muscle IIa , myosin-9 , non-muscle myosin heavy chain A , non-muscle myosin heavy chain IIa , non-muscle myosin heavy polypeptide 9 , nonmuscle myosin heavy chain II-A , NMMHC II-a , NMMHC-IIA , myosin, heavy polypeptide 9, non-muscle , NMMHC-A , nonmuscle myosin heavy chain-A , heavy polypeptide 9 , myosin heavy chain, nonmuscle , non-muscle IIa , type A , nonmuscle myosin II heavy chain A , flectin , myosin IIA , myosin heavy chain IX , fj85e11 , myosin, heavy chain 9, non-muscle, like-2 , zNMHC-IIA

GENE ID SPECIES
4627 Homo sapiens
481280 Canis lupus familiaris
25745 Rattus norvegicus
396469 Gallus gallus
398083 Xenopus laevis
404108 Bos taurus
100718592 Cavia porcellus
17886 Mus musculus
333938 Danio rerio
Selected quality suppliers for anti-Non-Muscle Myosin Heavy Polypeptide 9 (MYH9) Antibodies
Did you look for something else?